SCHEMBL801152

SCHEMBL801152

Cc1ccc(-c2cccc(-n3c4ccc(P(=O)(c5ccccc5)c5ccccc5)cc4c4cc(P(=O)(c5ccccc5)c5ccccc5)ccc43)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN5 P54829 1/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.38
▸ ALDH1A1 P00352 6/20 0.38
▸ LMNA P02545 3/20 0.38
▸ GAA P10253 2/20 0.38
▸ MAPT P10636 6/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ NR4A2 P43354 2/20 0.36
▸ HTT P42858 2/20 0.35
▸ FAAH O00519 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ MGLL Q99685 1/20 0.35
▸ GRM5 P41594 1/20 0.35
▸ POLB P06746 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL801452 0.96 NPSR1 (0.41) PTPN5NPSR1ALDH1A1LMNAGAA
SCHEMBL801114 0.90 ATM (0.44) NPSR1ALDH1A1GAAMAPTKDM4E
SCHEMBL801453 0.88 CYP19A1 (0.37) NPSR1ALDH1A1LMNAMAPTHTT
SCHEMBL801451 0.87 ATM (0.44) NPSR1ALDH1A1GAAMAPTKDM4E
SCHEMBL17589584 0.85 NPSR1 (0.42) NPSR1ALDH1A1LMNAGAAMAPT
SCHEMBL14948502 0.85 KDM4E (0.40) NPSR1ALDH1A1LMNAGAAMAPT
SCHEMBL801148 0.85 PPARG (0.37) NPSR1ALDH1A1LMNAMAPTKDM4E
SCHEMBL19238813 0.85 ATM (0.47) NPSR1ALDH1A1MAPTKDM4EMEN1
SCHEMBL801131 0.84 KDM4E (0.50) NPSR1ALDH1A1LMNAGAAMAPT
SCHEMBL19238819 0.84 ATM (0.49) NPSR1ALDH1A1LMNAGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INPP5B, EZH2, PLCB3 PTPN5 1233/4885NPSR1 4411/4885ALDH1A1 2562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback